Breadcrumb

Experimental Surgery and IRR Seminar Series Fall 2021
A novel cancer predisposition screening tool shows promise in helping doctors better predict which childhood cancer survivors may be at risk of developing...
The RI-MUHC Technology Platforms invite you to attend the Platform Expo Webinar on October 7, 2021.
Program and Centre Events
Meakins-Christie and RESP Program Seminar Series Fall 2021
MeDiC Program Seminar Series Fall 2021
Tuesdays, 4 to 5 p.m.
CRP Seminar Series Fall 2021
Access our servicesUse CrossLab (previously iLab) to book and access services.Follow these instructions if you need a new account.Consult...
RI-MUHC researcher Dr. Madhukar Pai is focused on global efforts to improve TB diagnosis and end TB
Equity, Diversity and Inclusion (EDI) at the RI-MUHCAt the Research Institute of the McGill University Health Centre (RI-MUHC), we are...
RI-MUHC ANNUAL REPORT 2021 FOCUS ON OUR TRAINEESWHAT IS OUR NEW GENERATION OF RESEARCHERS ACHIEVING TODAY?Over 1,200 research trainees play...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWINJURY REPAIR RECOVERY (IRR) PROGRAMRESEARCH HIGHLIGHTSPatients’ perspectives: “When will I...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWCANCER RESEARCH PROGRAM (CRP)RESEARCH HIGHLIGHTSOvercoming the resistance of bladder tumours to...
Congratulations to co-principal investigator Christina Wolfson from the RI-MUHC!
Congratulations to Anish Arora and Motahareh Vameghestahbanati!
Remembering a superb peptide chemist, exceptional collaborator and defender of student welfare
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWCHILD HEALTH AND HUMAN DEVELOPMENT (CHHD) PROGRAMRESEARCH HIGHLIGHTS$3.4M for new Centre for...
RI-MUHC ANNUAL REPORT 2021YEAR IN REVIEWBRAIN REPAIR AND INTEGRATIVE NEUROSCIENCE PROGRAM (BRaIN)RESEARCH HIGHLIGHTSA partnership with...
New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...
RI-MUHC ANNUAL REPORT 2021YOUR SUPPORTTOGETHER WE HAVE THE MEANS TO LEVERAGE DISCOVERIES THAT IMPROVE THE HEALTH OF PATIENTS ACROSS THEIR...
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells